CAS: 1346546-69-7
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
N-(1,3-benzothiazol-5-yl)-6-(propane-2-sulfonyl)-1,4-dihydroquinolin-4-imine REF: AN-AG01BDXKCAS: 1346546-69-7 | 99+% | 53.00 €~587.00 € | Thu 02 May 24 | |
GSK-872 REF: TM-T4074CAS: 1346546-69-7 | 99.3% | 38.00 €~1,140.00 € | Fri 03 May 24 | |
GSK 872 REF: 3D-BG166846CAS: 1346546-69-7 | Min. 95% | To inquire | Thu 13 Jun 24 |
N-(1,3-benzothiazol-5-yl)-6-(propane-2-sulfonyl)-1,4-dihydroquinolin-4-imine
CAS:1346546-69-7
Formula:
C19H17N3O2S2
Purity:
99+%
Color and Shape:
Solid
Molecular weight:
383.4872
Ref: AN-AG01BDXK
1mg | 53.00 € | |
5mg | 88.00 € | |
10mg | 109.00 € | |
25mg | 180.00 € | |
50mg | 218.00 € | |
100mg | 490.00 € | |
250mg | 587.00 € |
Estimated delivery in United States, on Thursday 2 May 2024
GSK-872
CAS:1346546-69-7
GSK-872 (GSK2399872A) is an effective and specific RIP3 kinase inhibitor. It binds RIP3 kinase domain …
Formula:
C19H17N3O2S2
Purity:
99.3%
Color and Shape:
Solid
Molecular weight:
383.49
Ref: TM-T4074
1mg | 38.00 € | |
2mg | 49.00 € | |
5mg | 78.00 € | |
10mg | 118.00 € | |
25mg | 184.00 € | |
50mg | 347.00 € | |
100mg | 517.00 € | |
500mg | 1,140.00 € | |
1ml*10 (DMSO) | 85.00 € |
Estimated delivery in United States, on Friday 3 May 2024
GSK 872
CAS:1346546-69-7
Inhibitor of RIPK3 kinase
Formula:
C19H17N3O2S2
Purity:
Min. 95%
Molecular weight:
383.49 g/mol
Ref: 3D-BG166846
10mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Thursday 13 Jun 2024